3588results about "Pharmaceutical packaging" patented technology

A pill container has a body, at least one lid, and at least one elastic assembly. The body comprises a first wall, a second wall, and at least one compartment. The first wall and second wall are two opposite sides of the body. The compartment is located between the first wall and the second wall. The lid is pivotably mounted on the second wall of the body. The elastic assembly is located on the second wall, and has a flexural segment and a first protruding section. The first protruding section is located on the flexural segment and contacts the second wall. The first protruding section supports a space between the flexural segment of the elastic assembly and the body.

A quick-fill pill organizer has a box, multiple retrieving covers, and a packaging cover. The box has multiple compartments. Each compartment has a retrieving opening and a packaging opening. The retrieving cover is mounted on the retrieving opening and corresponds to the compartment one-to-one such that the corresponding compartment connects to or is blocked from the outside. The packaging cover is mounted on the packaging openings such that all the compartments connect to or are blocked from the outside at the same time. When the retrieving openings are upward, the retrieving cover of the specific compartment can be opened. When the packaging openings are upward, the packaging cover can be opened or closed such that all of the compartments connect to or are blocked from outside at once.

The invention belongs to the field of biological medicine, and particularly relates to application of recombinant III-type humanized collagen in an injection. The invention provides an injection, the injection comprises recombinant III-type humanized collagen, the amino acid sequence of the recombinant III-type humanized collagen comprises n repetitions of the sequence as shown in SEQ ID NO.1, n is an integer greater than or equal to 1, and when n is an integer greater than or equal to 2, the repetitions are directly connected; moreover, when the injection is applied in one application period, the total application amount of the recombinant III-type humanized collagen is less than or equal to 3640 mg / kg. The recombinant III-type humanized collagen has high-dose injection safety, and can be applied in a single high-dose manner or continuously applied to realize high-dose application in a total amount level.

The invention relates to the technical field of coating surface preparation, in particular to an anticoagulant coating based on novel tick-derived anticoagulant protein Qinghaenin and a preparation method of the anticoagulant coating. The functional layer of the anticoagulant coating comprises the following components: anticoagulant protein Qinghaenin or a functional peptide fragment Qinghaenin 167-192 of the anticoagulant protein Qinghaenin, wherein the amino acid sequence of the functional peptide fragment is as shown in SEQ ID NO. 2. The preparation method of the anticoagulant coating comprises the following steps: by using a polydopamine coating as a substrate layer, covalently grafting through an amido bond, immobilizing anticoagulant protein Qinghaenin capable of inhibiting FXII factor activation or a functional peptide fragment Qinghaenin 167-192 thereof on the surface of a medical polymer material, and successfully constructing a novel anticoagulant coating. Compared with an unmodified medical polymer material, the modified coating can significantly enhance the hydrophilic performance of the material and inhibit platelet adhesion and activation, finally effectively prolongs the in-vitro blood coagulation time, and shows excellent anticoagulation performance.

The present disclosure relates to a container assembly including a multi-chamber container that fits within a protective outer sleeve. The container includes covers for allowing the chambers to be individually accessed. The container includes an integrated retention arrangement that allows the container to be secured within the outer sleeve in a manner in which unintended longitudinal movement between the outer sleeve and the container is prevented.

A container for organized storage and selective accessibility of items, such as medications. The container includes a base with a base plate and a central base hub, supporting the plurality of pill cases, each with a truncated sector shape and partitioned into two compartments accessible from opposing ends. The container incorporates a magnetic coupling system, comprising a plurality of primary magnetic elements on the base hub and a plurality of secondary magnetic elements on the pill cases, thereby enabling each pill case to attach to the base in one of two orientations, providing access to either compartment.

A container system with a recordable device having a substantially unaltered packaging profile when compared to standard commercially available prescription containers. The container includes a bottle having a cylindrical body having a length greater than its width. A cap is provided with an inclined spiral or helical land and stops to permit it to be affixed to the container. The cap is equipped with a snap fit ring or a fitting on its underside. A recording device is configured with a land or snap ring removably engageable with the snap fit ring on the underside of the cap. The cap has an aperture to accommodate a recording switch on the recording device. The cap is provided with a speaker switch aperture to permit the user to activate the message on the recording device to hear about the contents of the bottle.

A system and method is described for printing a label with an RFID tag. The system includes an RFID reader that queries a first RFID tag coupled to a first medicinal container that includes a medication. In response, the system receives a first unique identifier and uses the first unique identifier to determine a status of the medication, associate the first medicinal container with a medical provider and print a second label that includes a second RFID tag for a second medicinal container.

The invention relates to the technical field of automatic medicine dispensing, in particular to full-automatic high-speed liquid dispensing equipment and method, and the full-automatic high-speed liquid dispensing equipment comprises a liquid dispensing table, a raw material storage device, a liquid bag transfer manipulator and at least two liquid medicine mixing devices. Specifically, the raw material storage devices are arranged on the two sides of the liquid preparation table; and the liquid bag transfer manipulator is used for transferring the liquid bags in the raw material storage device to the liquid preparation table. The two liquid medicine mixing devices are arranged on the two sides, different from the raw material storage device, of the liquid preparation table respectively and used for taking and opening ampoule bottles and penicillin bottles in the raw material storage device, mixing agents in the ampoule bottles and the penicillin bottles and then injecting the mixed agents into a liquid bag to form finished liquid medicine. The medicine liquid mixing device comprises a liquid mixing table, and a medicine bottle opening mechanism, a medicine bottle transfer manipulator, a needle cylinder frame and a suction and injection manipulator which are arranged on the liquid mixing table. The application has the effects of improving the dispensing efficiency and the equipment utilization rate and expanding the application scene of the equipment.

Pill dispenser devices, systems and methods are shown and / or described herein. Include are a method, device or system for pill delivery including disposing a pill at a known location; contacting the pill with a pick-up member; and, moving the pill from the known location by movement of the pick-up member.

The present invention relates to liquid pharmaceutical compositions of clonidine or its pharmaceutically acceptable salts thereof. Preferably, the liquid pharmaceutical compositions are suitable for oral administration, and are stable for extended periods of time. More specifically, stable liquid pharmaceutical compositions of clonidine at concentrations of 1 μg / mL or more are provided. The present invention further relates to stable oral liquid compositions of clonidine, methods for their administration, processes for their production, and use of these compositions for treatment of diseases treatable by clonidine.

Provided herein are stable formulations containing active ingredients, such as antiviral compositions, or antiretroviral compositions in a powder form for reconstitution for intrarectal delivery to provide pre-exposure prophylaxis (PrEP) against viral infections. The antiviral composition may be tenofovir, for HIV PrEP.

The invention provides a medical stent and a preparation method thereof.The preparation method comprises the steps that an anti-coagulation coating is arranged on at least part of the surface of the medical stent through physical coating, then an anti-hyperplasia coating is arranged on at least part of the surface of the medical stent through physical coating, the anti-coagulation coating comprises a copolymer, and the anti-hyperplasia coating comprises an anti-hyperplasia coating. A copolymer in the anticoagulant coating contains a zwitterionic unit and an adsorption unit, and the anti-hyperplasia coating contains an anti-hyperplasia drug and a degradable polymer; or, an anti-hyperplasia and anti-coagulation integrated coating is arranged on at least part of the surface of the medical stent through physical coating, the integrated coating contains a copolymer and an anti-hyperplasia drug, and the copolymer in the integrated coating contains a zwitter-ion unit, an adsorption unit and a degradable unit; the adsorption unit is an ester unit containing a carbon-carbon double bond, and the degradable unit is a 2-methylene-1, 3-dioxane unit. The problem that thrombus and restenosis exist at the same time after the stent is implanted can be solved, the binding force between the coating and the substrate is improved, and the falling risk of the coating is reduced.

This invention belongs to the field of medical syringe technology, specifically referring to a syringe connector, including a main body with an inlet end and an outlet end. The inlet end connects to the syringe. The main body has a flow channel with both ends communicating, and a sealing element is placed within the flow channel, dividing the flow channel into an inlet channel and an outlet channel. After the connector is connected to the needle, the needle passes through the sealing element and extends into the inlet channel, allowing liquid from the syringe to flow into the needle. The main body can take various shapes, as long as both ends are cylindrical. A common design is a tubular structure for the entire main body. The inlet end enables the connector to be matched with the syringe; the outlet end enables the needle to be matched with the connector. The connector acts as a carrier to connect the syringe to a mismatched needle. Furthermore, the syringe connector can prevent the waste of existing resources in the market.

The invention relates to the related technical field of medical instruments, in particular to a contrast injection device for enhancing nuclear magnetic resonance, which comprises a base, a mounting shell arranged at the upper part of the base, a first barrel arranged at the left upper part in the mounting shell, a second barrel arranged at the right upper part in the mounting shell, and a mixing barrel arranged in the middle of the upper part of the mounting shell, a first piston rod is arranged in the first barrel, a second piston rod is arranged in the second barrel, communicating pipes are respectively communicated between the first barrel and the mixing barrel and between the second barrel and the mixing barrel, a one-way water inlet pipe is arranged at the top of the barrel, and the one-way water inlet pipe is communicated with an external liquid storage tank. By rotating the adjusting screw rod, the adjusting screw rod drives the first wedge-shaped block to move to the position of the needed dosage, then the rodless air cylinder controls the extrusion plate to move upwards, and after the extrusion plate moves upwards and makes contact with the plate body, the piston rods move upwards to inject the contrast agent and normal saline of the corresponding dosage into the mixing barrel to be mixed.

The invention relates to an assembly formed by a medical device (1) adapted to be implanted in a human or animal body and by packaging, wherein: —the medical device comprises a housing (11) that encloses a fluid reservoir (13) and a fluid outlet (12) forming a fluid connection between the reservoir and a volume outside the housing; —the packaging includes a tank (2) comprising a bottom (20), a side wall (21), an upper face opposite the bottom in a vertical direction, and an opening configured to fill the tank with a biocompatible fluid, the bottom (20) of the tank extending in a horizontal plane perpendicularly to the vertical direction; —at least one of the bottom, the side wall and the top face comprises a first holding element (201) adapted to hold the housing in the tank, the housing (11) being held in the tank (2) by said first holding element (201) such that the reservoir is located between the bottom of the tank and the fluid outlet, said fluid outlet being arranged below the opening such that the fluid outlet is immersed in the fluid when the tank is filled with the biocompatible fluid.

A paper bottle system for pharmaceuticals is disclosed. The system includes a first frustum-shaped conical section formed of heavy-weight paper, a second frustum-shaped conical section formed of a biodegradable material, a biodegradable lid, and an aqueous coating. The conical sections are angled between 5-8 degrees from vertical, allowing for efficient nesting and stacking. The system is designed to be environmentally friendly, easily recyclable, and optimized for short-term use. When disposed of in a landfill, the paper bottle system quickly breaks down, contributing to soil health and reducing environmental impact.

An infant feeding apparatus. The bottle includes a bottle having an open connecting end, a resilient teat member connected to the open connecting end, in which the teat member has a collapsible base, the collapsible base which has two connectors. The collapsible base has a corrugated sidewall defining an inner chamber. One the connector has a first outer indent and an inner anchor receiver disposed towards the inner chamber. The other connector has second outer indent. A capsule has two ends and is sized and shaped for location in the inner chamber and has amount of powder. A cutting member is located near one capsule end and has an anchor extension to lock with the inner anchor receiver. Another cutting member is located near the other capsule end and is connected to the open connecting end of the bottle. A teat holder is located to lockingly hold the connector portion nd the cutting member. A pushing member is connected to the connector portion of the resilient teat member and is disposed to permit a pushing force to be applied against it to collapse the collapsible base portion and to cut capsule ends to release the powder into the bottle.

The utility model relates to the technical field of medical auxiliary equipment, in particular to an operation rotary table for infusion and injection and a multifunctional clamp thereof, the operation rotary table for infusion and injection and the multifunctional clamp thereof comprise a circular clamp body, and the clamp body is sequentially provided with an upper positioning groove, a limiting groove and a lower positioning groove which are communicated with one another in the axis direction; the upper positioning groove, the limiting groove and the lower positioning groove form openings in the side wall of the clamp body, the upper positioning groove and the lower positioning groove penetrate through the upper end face and the lower end face of the clamp body respectively, the width of the upper positioning groove is smaller than that of the lower positioning groove, and the width of the lower positioning groove is smaller than that of the limiting groove. According to the multifunctional clamp, after the puncture opening is clamped in, the multifunctional clamp is rotated, the opening is closed through the inner wall of the rotating disc used for installing the multifunctional clamp, and therefore the puncture opening can be fixed, and the multifunctional clamp can be suitable for installation of various puncture openings.

This container adapter (10) for a syringe comprises a main body (12), having a lateral configuration suitable for entering by force into a container opening while being adapted to the complementary shape of an inner lateral wall of this container opening, and a through-hole (22), formed longitudinally in the main body (12), for insertion of a sampling endpiece of the syringe. It further comprises a head stopper (24), integral with the main body (12), having an insertion pin (26) shaped to enter by force into the through-hole (22) and seal the latter hermetically.

In certain embodiments, a vial adaptor comprises a housing configured to couple the adaptor with a vial, an access channel, a regulator channel, and a regulator assembly. The access channel is configured to facilitate withdrawal of fluid from the vial when the adaptor is coupled to the vial. The regulator channel is configured to facilitate a flow of a regulating fluid from the regulator assembly to compensate for changes in volume of a medical fluid in the vial. The regulator assembly can include a valve configured to transition between a closed configuration and an opened configuration.

To provide a method for transporting thermoplastic resin vials under sterile conditions and in an exogenous pyrogen-free state, introducing the vials into a filling assembly line, and thereafter allowing the vials to stand without tipping or dropping them, the method is a method for packing vials for filling with contents such as medicaments or cells by vacuum-packing the vials, and includes the following steps:(I) inserting a plurality of vials in a tray with opening portion sides of the vials facing a bottom of the tray,(II) installing a soft film on bottom portions of the vials,(III) introducing the tray having the vials installed therein and the soft film into a gas-impermeable flexible film bag,(IV) depressurizing the inside of the flexible film bag to a prescribed vacuum pressure, and(V) sealing an opening of the flexible film bag.

A lyophilization container includes a first section having a first layer, a second layer aligned with the first layer, and a cavity defined by the alignment of the first and second layers, where at least one of the first and second layers is preformed to have a three-dimensional shape. A lyophilization fixture includes a base member and a lid member. The lid member is movable between a first position and a second position relative to the base member. The base member and lid member together define a housing that receives at least a portion of a lyophilization container.

The present invention generally relates to packaging systems embedded with adsorbent materials, more particularly, it relates to materials used in packaging of pharmaceuticals for actively adsorbing volatile compounds and moisture.

To provide an ophthalmic product in which an ophthalmic composition is filled in a container in which a pressing deformation part is formed by using an elastic material, and although the ophthalmic composition contains chlorpheniramine, diphenhydramine or a salt thereof, adsorption of these components is suppressed.SOLUTION: An ophthalmic product comprising an ophthalmic composition and a container filled with the ophthalmic composition, wherein the container comprises a container body having a discharge port and a press-deforming part, and a cap, and the press-deforming part is formed using an elastic material, (A) one or more selected from the group consisting of chlorpheniramine, diphenhydramine, and pharmaceutically acceptable salts thereof, and (B) one or more selected from the group consisting of an amino acid and a salt thereof, glycyrrhizic acid and a salt thereof, a mucopolysaccharide and a salt thereof, trometamol and a salt thereof, ethylenediaminetetraacetic acid and a salt thereof, and a vitamin and a derivative thereof.SELECTED DRAWING: Figure 1

The invention provides pharmaceutical compositions comprising about 0.05 to 0.1% (w / v) cyclosporine dissolved in 1-perfluorobutyl-pentane for use in the topical treatment of dry eye disease and provides for dosing and treatment methods thereof. The invention further provides kits comprising such compositions.

The invention provides a one-person one-prescription traditional Chinese medicine patch preparation machine which comprises a production machine workbench, and the production machine workbench is provided with a protective film feeding frame, a stirring mechanism, a paste extruding mechanism, a pre-pressing mechanism, a uniform pressing mechanism, a cutting mechanism, a medicine patch cloth feeding and recycling assembly, a waste recycling frame, a discharging mechanism and a plurality of storage containers. The protective film feeding frame, the stirring mechanism, the paste extruding mechanism, the pre-pressing mechanism, the uniform pressing mechanism, the cutting mechanism and the discharging mechanism are sequentially arranged from left to right, the stirring mechanism and the paste extruding mechanism are provided with a stirring fast-assembling position and a paste extruding fast-assembling position respectively, the stirring fast-assembling position and the paste extruding fast-assembling position are each provided with a positioning wall, and fast-assembling clamping blocks are arranged on the positioning walls. The storage container is provided with a quick-mounting clamping hole, the protective film feeding frame is provided with a protective film, the protective film is arranged below the stirring mechanism and the paste extruding mechanism, and the patch cloth feeding and recycling assembly is provided with patch cloth. The device has the beneficial effects that a user can quickly detach and clean the storage container, and the requirements of the user are met.